SGLT

15 Item(s)

per page

Set Descending Direction
  1. Dapagliflozin (BMS512148)

    Catalog No. A10285
    Quick View
    SGLT2 inhibitor
    Dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Learn More
  2. Dapagliflozin impurity

    Catalog No. A19103
    Quick View
    SGLT2 inhibitor
    Dapagliflozin impurity is an enantiomer of Dapagliflozin which is a sodium-glucose transporter 2 inhibitor. Learn More
  3. SGL5213

    Catalog No. A18723
    Quick View
    SGLT1 inhibitor
    SGL5213 is a potent, oral active and low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor, with IC50 values of 29 nM and 20 nM for hSGLT1 and hSGLT2, respectively. Learn More
  4. Ertugliflozin L-pyroglutamic acid

    Catalog No. A18054
    Quick View
    SGLT inhibitor
    Ertugliflozin pidolate belongs to the class of potent and selective inhibitors of the sodium-dependent glucose cotransporters (SGLT), more specifically the type 2 which is responsible for about 90% of the glucose reabsorption from glomerulus. Learn More
  5. Canagliflozin hemihydrate

    Catalog No. A16817
    Quick View
    SGLT2 inhibitor
    Canagliflozin hemihydrate is the hemihydrate form of canagliflozin, which is a SGLT2 inhibitor with IC50 of 2.2 nM for hSGLT2 in a cell-free assay, exhibits 413-fold selectivity over hSGLT1. Learn More
  6. T-1095

    Catalog No. A15463
    Quick View
    Na+-glucose transporter inhibitor
    T-1095 is a potent and selective inhibitor of Na+-glucose cotransporters (SGLTs). Learn More
  7. Luseogliflozin

    Catalog No. A13476
    Quick View
    SGLT2 Inhibitor
    Luseogliflozin is an orally active second-generation sodium-glucose co-transporter 2 (SGLT2) inhibitor developed by Taisho Pharmaceutical for the treatment of patients with type 2 diabetes mellitus (T2DM). Learn More
  8. Ipragliflozin

    Catalog No. A13556
    Quick View
    SGLT2 inhibitor
    Ipragliflozin is a highly potent and selective SGLT2 inhibitor with IC50 of 2.8 nM; little and NO potency for SGLT1/3/4/5/6. Learn More
  9. Remogliflozin

    Catalog No. A13971
    Quick View
    SGLT2 inhibitor
    Remogliflozin inhibits the sodium-glucose transport (SGLT2) proteins, which are responsible for glucose reabsorption in the kidney. Learn More
  10. Tofogliflozin

    Catalog No. A12690
    Quick View
    SGLT2 inhibitor
    Tofogliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Learn More
  11. LX-4211

    Catalog No. A12680
    Quick View
    SGLT Inhibitor‎
    LX4211 is a Dual SGLT1/SGLT2 Inhibitor Learn More
  12. Empagliflozin

    Catalog No. A12440
    Quick View
    Empagliflozin is a potent, selective sodium glucose co-transporter-2 inhibitor that is in development for the treatment of type 2 diabetes. Learn More
  13. EGT1442

    Catalog No. A10155
    Quick View
    SGLT2 inhibitor
    EGT1442 is a potent and selective SGLT2 inhibitor. Learn More
  14. Canagliflozin

    Catalog No. A11100
    Quick View
    SGLT2 Inhibitor
    Canagliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2). Learn More
  15. Licogliflozin

    Catalog No. A12828
    Quick View
    SGLT1/SGLT2 inhibitor
    Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor. Learn More

15 Item(s)

per page

Set Descending Direction
Rewards